FeNO for the diagnosis and management of asthma

A new report is showcasing the impact of a national AHSN Network programme to improve access to FeNO testing for asthma diagnosis. Fractional exhaled Nitric Oxide (FeNO) tests are simple, non-invasive tests to support the diagnosis of asthma. During the two-year programme an estimated 58,000 new asthmatics received a faster, more accurate diagnosis through the use of FeNO testing with an additional 1,200 devices entering use in primary care in England.

These products are referenced in more detail in NICE Diagnostic Guidance 12 (DG12)

Help to construct your business case to enable sustainable adoption of FeNO and also to think about areas of funding that might not have been considered

This FeNO training package consists of 2 educational modules, primarily targeted at a primary care audience, however any health professional may complete this course.

Developed by Wessex AHSN, here you can find useful links to FeNO Guidance for the diagnosis and treatment of asthma

Wessex AHSN have developed a number of resources to support you to develop your FeNO project using QI methodology.

accuRx has created a FeNO template to send to patients prior to their appointment via text message. For information on what's included and how to find the template, have a look at the guidance document below.

As with any test or procedure it is really important that your patient has a full understanding of what to expect from their FeNO test appointment, along with an explanation of the test process.